PolyPid to Present at the Barclays Global Healthcare Conference
Mar 15 - Mar 17, 2022
PETACH TIKVA, Israel, March 01, 2022 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a Phase 3 biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology, today announced that it will present at the Barclays Global Healthcare Conference, which is being held in Miami, Florida, on March 15-17, 2022.
Barclays Global Investor Conference:
|Presentation Date:||Wednesday, March 16, 2022|
|Presentation Time:||9:00 AM Eastern Time|